# Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors

> **NCT00550901** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 25 (estimated)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** cisplatin
- **DRUG:** dexrazoxane hydrochloride
- **OTHER:** high performance liquid chromatography
- **OTHER:** laboratory biomarker analysis
- **OTHER:** mass spectrometry
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00550901
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2015-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00550901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00550901, "Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00550901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*